Dr. Ramalingam on Myths & Facts, Question and Answer Session

[NikoleV]

Dr. Ramalingam on Myths & Facts, Question and Answer Session on Clinical Trials

February 8th, 2013 - by Dr. Jack West

http://expertblog.lungevity.org/2013/02 ... s-3-and-4/

Here’s the last two parts of our webinar program with Dr. Suresh Ramalingam, medical oncologist and Director of Medical Oncology at Emory University, as well as Chair of the ECOG Lung Cancer Committee. The last portion of Dr. Suresh Ramalingam’s presentation covered several persistent myths around clinical research in cancer, countered with the real facts, and then included a highlighting of patient rights in clinical trials.

Here are the video and audio versions of this last portion of his presentation, along with the transcript and figures.

(Click link above to view video and audio links)

Ramalingam Pt 3 Clin Trials in Cancer Video

Ramalingam Pt 3 Clin Trials in Cancer Audio

Ramalingam Pt 3 Clin Trials in Cancer Transcript

Ramalingam Pt 3 Clin Trials in Cancer Figures

The program closed with a question and answer session covering emerging challenges of doing trials in a new era of molecular oncology. As a large population like “advanced lung cancer” becomes divided into many subgroups, even with some small ones like the 4% with an ALK rearrangement and perhaps even 1-3% populations with others on the horizon, we face new challenges in conducting clinical trials on small and widespread populations.

How will we continue to do clinical research on these smaller, scattered populations? Dr. Ramalingam offers his insights in the Q&A portion (because there really isn’t anything visual in this part, there’s no real video to see).

(Click link above to view audio & transcript links)

Ramalingam Pt 4 QA Session Clin Trials in Cancer Audio

Ramalingam Pt 4 Clin Trials in Cancer Pt 4 Transcript

I hope this is helpful. We’ll be sharing the next program very soon.